Australia markets close in 18 minutes

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
50.49+1.11 (+2.25%)
At close: 04:00PM EDT
50.49 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-235,464
-214,529
-163,918
-107,641
-73,812
Depreciation & amortisation
1,289
1,098
983
922
948
Stock-based compensation
46,295
40,937
28,268
17,352
10,427
Change in working capital
11,423
8,044
18,612
1,096
376
Accounts receivable
-
14,648
10,994
6,293
2,723
Accounts payable
-
-
-
6,293
2,723
Other working capital
-184,449
-170,995
-116,861
-89,024
-62,213
Other non-cash items
1,884
-790
406
-739
261
Net cash provided by operating activities
-178,445
-166,307
-115,205
-88,588
-62,027
Cash flows from investing activities
Investments in property, plant and equipment
-6,004
-4,688
-1,656
-436
-186
Purchases of investments
-609,927
-532,857
-329,817
-125,404
-135,592
Sales/maturities of investments
367,072
337,132
157,493
69,357
135,995
Net cash used for investing activities
-248,859
-200,413
-173,980
-56,483
217
Cash flows from financing activities
Debt repayment
0
-
-
-
-
Common stock issued
752,234
369,019
117,242
249,542
114,283
Common stock repurchased
-
-
-
0
0
Net cash used provided by (used for) financing activities
782,034
388,944
121,963
252,679
114,571
Net change in cash
354,730
22,224
-167,222
107,608
52,761
Cash at beginning of period
42,494
33,973
201,195
93,587
40,826
Cash at end of period
397,224
56,197
33,973
201,195
93,587
Free cash flow
Operating cash flow
-178,445
-166,307
-115,205
-88,588
-62,027
Capital expenditure
-6,004
-4,688
-1,656
-436
-186
Free cash flow
-184,449
-170,995
-116,861
-89,024
-62,213